Home » Stocks » Artemis Therapeutics

Artemis Therapeutics, Inc. (ATMS)

Stock Price: $0.0400 USD 0.0000 (0.00%)
Updated Jul 27, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 206,120
Revenue (ttm) n/a
Net Income (ttm) -58,000
Shares Out 5.15M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 27, 2020
Last Price $0.0400
Previous Close $0.0400
Change ($) 0.0000
Change (%) 0.00%
Day's Open 0.0360
Day's Range 0.0360 - 0.0360
Day's Volume 108
52-Week Range 0.0320 - 0.4500

More Stats

Market Cap 206,120
Enterprise Value 203,120
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 5.15M
Float 1.66M
EPS (basic) -0.013
EPS (diluted) -0.02
FCF / Share 0.00
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta -6.17
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 50.52
Revenue n/a
Operating Income -154,000
Net Income -58,000
Free Cash Flow -10,000
Net Cash 3,000
Net Cash / Share 0.00
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -409.31%
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$175.00*
Low
175
Current: $0.0400
High
175
Target: 175.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172015201420132012201120102009
Revenue----0.241.291.063.752.813.01
Revenue Growth-----81.06%21.39%-71.69%33.29%-6.7%-
Gross Profit----0.200.720.542.862.362.64
Operating Income-0.17-0.77-1.04-0.16-0.35-0.35-0.96-0.270.091.59
Net Income-0.12-0.51-1.14-0.140.36-0.30-1.08-0.494.89-1.47
Shares Outstanding5.155.154.890.860.860.860.860.840.740.33
Earnings Per Share-0.02-0.08-0.20-0.50-0.50-1.50-0.506.00-4.50
Operating Cash Flow-0.11-0.52-0.93-0.190.47-0.25-1.300.07-0.910.96
Capital Expenditures----0.01--0.01-0.02-0.01-0.01
Free Cash Flow-0.11-0.52-0.93-0.190.48-0.25-1.300.04-0.920.96
Cash & Equivalents0.000.010.530.660.850.370.611.912.182.80
Total Debt---------8.88
Net Cash / Debt0.000.010.530.660.850.370.611.912.18-6.09
Assets0.020.030.580.710.900.701.162.982.843.66
Liabilities0.260.320.480.060.110.280.421.231.2910.66
Book Value-0.24-0.300.100.650.790.430.741.751.55-7.00
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Artemis Therapeutics, Inc.
Country United States

Stock Information

Ticker Symbol ATMS
Stock Exchange US OTC
Unique Identifier OTCMKTS: ATMS

Description

Artemis Therapeutics Inc. does not have significant operations. Previously, it was engaged in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company was incorporated in 1997 and is based in New York, New York.